Viemed Healthcare, Inc. (VMD)
NASDAQ: VMD · Real-Time Price · USD
7.37
+0.15 (2.08%)
At close: Dec 15, 2025, 4:00 PM EST
7.50
+0.13 (1.76%)
After-hours: Dec 15, 2025, 4:50 PM EST
Viemed Healthcare Market Cap
Viemed Healthcare has a market cap or net worth of $280.19 million as of December 15, 2025. Its market cap has decreased by -16.90% in one year.
Market Cap
280.19M
Enterprise Value
294.15M
1-Year Change
-16.90%
Ranking
Category
Stock Price
$7.37
Market Cap Chart
Since January 4, 2018, Viemed Healthcare's market cap has increased from $67.99M to $280.19M, an increase of 312.08%. That is a compound annual growth rate of 19.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 274.49M | -12.10% |
| Dec 31, 2024 | 312.27M | 3.35% |
| Dec 29, 2023 | 302.14M | 5.12% |
| Dec 30, 2022 | 287.43M | 39.02% |
| Dec 31, 2021 | 206.75M | -31.94% |
| Dec 31, 2020 | 303.77M | 29.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |